Dry ARMD -Valeda Photobiomodulation Light Therapy
Valeda Photobiomodulation Therapy is an innovative, non-invasive treatment designed to improve retinal health. Approved by the European CE Mark, this therapy uses safe, low-level light to stimulate cell repair and improve retinal function. It is primarily used to treat early stages of Dry Age-Related Macular Degeneration (Dry AMD).
How Does Valeda Work?
The Valeda system utilises advanced photobiomodulation technology to deliver carefully controlled wavelengths of light to the retina in a painless, non-invasive procedure. This specialised light therapy stimulates energy production within the retinal cells, enhancing their ability to repair and regenerate while reducing harmful inflammation.
By improving cellular metabolism, Valeda not only aims to preserve vision but also slows the progression of Dry Age-Related Macular Degeneration (Dry AMD). The treatment is designed to support the overall health of retinal cells, offering a promising approach for managing Dry AMD and maintaining visual function over time.
Benefits of Valeda Therapy
Non-Invasive:
The procedure is completely painless and does not require surgery or injections.
Quick Treatment:
Each session lasts only a few minutes, making it a convenient option.
Slows Disease Progression:
Helps maintain vision by targeting early-stage Dry AMD before significant damage occurs.
Safe and Proven:
Backed by clinical studies and approved for use across Europe.
Treatment Process
Valeda therapy is delivered over several sessions, typically completed within a few weeks. Patients sit comfortably while a specialised light is directed into the eyes. There is no downtime required, allowing individuals to resume daily activities immediately after treatment.
Using Targeted Wavelengths
The Valeda system utilises three targeted wavelengths of light—590 nm, 660 nm, and 850 nm—each playing a distinct role in promoting retinal cell health:
590 nm:
Reduces vascular endothelial growth factor (VEGF) expression, helping to minimise abnormal blood vessel growth, and aids in the removal of cellular deposits.
660nm:
Enhances oxygen binding and stimulates the production of adenosine triphosphate (ATP), which helps to reduce inflammation and prevent cellular loss.
850 nm:
Boosts metabolic activity and ATP production, reduces inflammation and cellular loss, and facilitates electron transfer to support cell function.
Why Choose The Forbury Clinic?
Choosing The Forbury Clinic for Valeda Photobiomodulation Therapy means accessing expert care from experienced ophthalmologists who specialise in advanced retinal treatments. We use the latest Valeda technology to deliver safe, non-invasive therapy that targets early stage Dry AMD effectively. Our patient focused approach ensures personalised care tailored to your specific needs, prioritising your comfort and helping to protect your vision for the future.